Literature DB >> 19365635

Interleukin-6, interleukin-10 and interleukin-12 in vaginal fluid from women with bacterial vaginosis.

T Weissenbacher1, C Walter, I Mylonas, C Scholz, A Gingelmaier, K Friese.   

Abstract

BACKGROUND: There has been a recent recognition on the influence of local vaginal immunity on the acquisition of vulvovaginal disorders and their adverse consequences. Variations in local immune responses seem to play an important role in susceptibility to different vaginal infections as well as to the likelihood of recurrences. Bacterial vaginosis (BV), the most frequent vaginal disorder in most populations, is enigmatic in that the etiology is unknown, recurrences are common and vaginal inflammation is absent. We investigated the influence of BV on the vaginal concentration of the pro-inflammatory cytokine interleukin (IL)-12, the pleiotropic cytokine IL-6 and the anti-inflammatory cytokine IL-10 in non-pregnant women.
METHODS: Vaginal lavage samples were obtained from 45 patients with BV and from 46 asymptomatic controls. The supernatant fractions were examined for IL-6, IL-10 and IL-12 by commercial ELISAs. Analysis of the cytokine levels in the two groups was by the Mann-Whitney test.
RESULTS: IL-6 concentrations varied considerably among women in the BV and control groups but the median levels were almost identical. The median concentrations of IL-10 and IL-12 were uniformly low in both groups but median levels were not statistically different.
CONCLUSION: The marked alteration in the vaginal bacterial flora that is characteristic of BV does not result in enhancement or inhibition of the vaginal levels of IL-6, IL-10 and IL-12. Mechanisms to explain this striking lack of immune system variation remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365635     DOI: 10.1007/s00404-009-1072-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.

Authors:  Sylvie Miquel; Julien Verlaguet; Sophie Garcin; Thomas Bertran; Bertrand Evrard; Christiane Forestier; Marjolaine Vareille-Delarbre
Journal:  Infect Immun       Date:  2022-08-24       Impact factor: 3.609

Review 2.  Bacterial vaginosis and the cervicovaginal immune response.

Authors:  Caroline Mitchell; Jeanne Marrazzo
Journal:  Am J Reprod Immunol       Date:  2014-06       Impact factor: 3.886

3.  Ureaplasma urealyticum and U. parvum in sexually active women attending public health clinics in Brazil.

Authors:  T N Lobão; G B Campos; N N Selis; A T Amorim; S G Souza; S S Mafra; L S Pereira; D B Dos Santos; T B Figueiredo; L M Marques; J Timenetsky
Journal:  Epidemiol Infect       Date:  2017-06-22       Impact factor: 4.434

4.  Evaluation of Cytokines in Endocervical Secretion and Vaginal pH from Women with Bacterial Vaginosis or Human Papillomavirus.

Authors:  Ana Claudia Camargo Campos; Eddie Fernando Candido Murta; Márcia Antoniazi Michelin; Cleomenes Reis
Journal:  ISRN Obstet Gynecol       Date:  2012-03-22

5.  Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis.

Authors:  Nicole M Gilbert; Warren G Lewis; Amanda L Lewis
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

Review 6.  Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities.

Authors:  Mathys J Redelinghuys; Janri Geldenhuys; Hyunsul Jung; Marleen M Kock
Journal:  Front Cell Infect Microbiol       Date:  2020-08-11       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.